Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q1 CY2026, with sales up 21% year on year to $166.3 million.

Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday afternoon. Here’s what investors ...

Engineering and scientific consulting firm Exponent Inc (NASDAQ:EXPO) shares are skyrocketing after the company reported better-than-expected first-quarter FY24 earnings. Exponent reported ...

(EXPO) on Thursday reported earnings of $29.6 million in its first quarter. The Menlo Park, California-based company said it had profit of 59 cents per share. The engineering and scientific consulting ...

Exponent ( (EXPO)) has issued an update. On April 30, 2026, Exponent, Inc. reported strong first quarter 2026 results, with total revenues rising 14% year over year to $166.3 million and revenues ...

Exponent is a business that we have admired from the sidelines for a while, and we finally saw an opportunity to initiate a position at an attractive price due to a rare pause in annual growth. No ...

Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026. "Exponent delivered ...

Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares ...